Employers and employees will be able to book a test directly for themselves or members of their household who are experiencing symptoms
News
AZ, Saint Luke’s begin testing Farxiga for COVID-19
DARE-19 will determine whether Farxiga can hold back disease progression and reduce the risk of clinical complications and death
Pharmacists warn of issues with social distancing, PPE
Forty percent of pharmacists surveyed said they were unable to maintain social distancing from patients
EC nod for merger of Mylan and Pfizer’s Upjohn division
The decision ensures that the merger between Mylan and Upjohn does not harm competition
Novartis’ Jakavi bests current therapy for GvHD
REACH2 is the first Phase III study in steroid-refractory acute graft-versus-host-disease (GvHD) to have met its primary endpoint
NICE backs NHS use of Bayer’s Vitrakvi via the CDF
The drug was initially considered too expensive but its cost to the NHS has been lowered
Bayer partners with Population Health Research Institute on COVID-19 research
Two clinical research studies in the programme will assess the safety and efficacy of different combination therapies
Charity launches online support services for self-isolators with MS
Calls to the MS helpline have increased significantly
Novartis highlights benefits of Mayzent in MS
The data underscore the advantages of early treatment initiation, the firm notes
UK COVID-19 vaccine to begin human testing
The government has given £42.5 million to support vaccine projects at Oxford University and Imperial College London
Novartis to test hydroxychloroquine for coronavirus
The study follows early preclinical and clinical evidence that hydroxychloroquine may be beneficial in the fight against the virus
New research to assess extent of COVID-19 infection in young
The What’s the STORY study at University of Oxford will collect blood samples from children and teenagers aged 0-19 years
Opdivo/Cabometyx combo hits targets in first-line kidney cancer
The combination significantly increased progression free survival when used as a first-line treatment
Researchers find potential new target for eye disease therapy
This research is the first to describe a role for SARM1 in photoreceptor cell biology
Epsilogen licences experimental IgE antibody from KCL
The antibody, developed at KCL in collaboration with Cancer Research UK, is the first therapeutic IgE antibody to enter clinical trials
